Thomas F Scott1, Carol J Schramke. 1. Drexel University College of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA. tscott@wpahs.org
Abstract
OBJECTIVE: Examine the relative importance of several risk factors for progression, in a large sample of MS patients. METHODS: Using a retrospective design in a single university-based MS treatment center, we studied 207 patients with relapsing remitting MS diagnosed, treated at our center, evaluated within one year of their second attack, and at least 2 years after their first attack. Risk factors were: 1) age greater than 40 at first attack; 2) more than 2 attacks in the 2 years from onset; 3) EDSS >1.5 after second attack (poor recovery); 4) male gender; and 5) motor symptoms at onset. Groups were defined as having a few (0 to 2) or many (3 to 5) risk factors. RESULTS: Two hundred seven patients were followed for an average of 94 months (SD=44). 30% were over 40 years of age at onset, 38% had more than 2 attacks in 2 years, 28% had an EDSS >1.5 after the second attack (i.e., had poor recovery), 24% were male, and 58% had motor symptoms at onset. Regression analysis and Kaplan-Meier survival curves that suggested poor recovery after the first two attacks were the best individual predictors of progression at 5 years after initial diagnosis. In addition, having many individual risk factors was associated with having a higher risk of progression (p<.001 by Mann Whitney U, sustained final EDSS at an average disease duration of 9.7 years). CONCLUSIONS: This study suggests a paramount importance of recovery from early attacks, as well as an additive effect of individual risk factors for progression of MS in the first several years after diagnosis. Copyright 2010 Elsevier B.V. All rights reserved.
OBJECTIVE: Examine the relative importance of several risk factors for progression, in a large sample of MS patients. METHODS: Using a retrospective design in a single university-based MS treatment center, we studied 207 patients with relapsing remitting MS diagnosed, treated at our center, evaluated within one year of their second attack, and at least 2 years after their first attack. Risk factors were: 1) age greater than 40 at first attack; 2) more than 2 attacks in the 2 years from onset; 3) EDSS >1.5 after second attack (poor recovery); 4) male gender; and 5) motor symptoms at onset. Groups were defined as having a few (0 to 2) or many (3 to 5) risk factors. RESULTS: Two hundred seven patients were followed for an average of 94 months (SD=44). 30% were over 40 years of age at onset, 38% had more than 2 attacks in 2 years, 28% had an EDSS >1.5 after the second attack (i.e., had poor recovery), 24% were male, and 58% had motor symptoms at onset. Regression analysis and Kaplan-Meier survival curves that suggested poor recovery after the first two attacks were the best individual predictors of progression at 5 years after initial diagnosis. In addition, having many individual risk factors was associated with having a higher risk of progression (p<.001 by Mann Whitney U, sustained final EDSS at an average disease duration of 9.7 years). CONCLUSIONS: This study suggests a paramount importance of recovery from early attacks, as well as an additive effect of individual risk factors for progression of MS in the first several years after diagnosis. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Scott D Newsome; Philip J Aliotta; Jacquelyn Bainbridge; Susan E Bennett; Gary Cutter; Kaylan Fenton; Fred Lublin; Dorothy Northrop; David Rintell; Bryan D Walker; Megan Weigel; Kathleen Zackowski; David E Jones Journal: Int J MS Care Date: 2016 Nov-Dec
Authors: Martina Novotna; M Mateo Paz Soldán; Nuhad Abou Zeid; Nilufer Kale; Melih Tutuncu; Daniel J Crusan; Elizabeth J Atkinson; Aksel Siva; B Mark Keegan; Istvan Pirko; Sean J Pittock; Claudia F Lucchinetti; John H Noseworthy; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci Journal: Neurology Date: 2015-07-24 Impact factor: 9.910
Authors: Thomas F Scott; Troy Desai; Chris Hackett; Edward J Gettings; Teresa Hentosz; Wisam Elmalik; Carol J Schramke Journal: Int J MS Care Date: 2019-12-05
Authors: Marinos G Sotiropoulos; Hrishikesh Lokhande; Brian C Healy; Mariann Polgar-Turcsanyi; Bonnie I Glanz; Rohit Bakshi; Howard L Weiner; Tanuja Chitnis Journal: Mult Scler J Exp Transl Clin Date: 2021-05-28
Authors: Bruce A C Cree; Jill A Hollenbach; Riley Bove; Gina Kirkish; Simone Sacco; Eduardo Caverzasi; Antje Bischof; Tristan Gundel; Alyssa H Zhu; Nico Papinutto; William A Stern; Carolyn Bevan; Andrew Romeo; Douglas S Goodin; Jeffrey M Gelfand; Jennifer Graves; Ari J Green; Michael R Wilson; Scott S Zamvil; Chao Zhao; Refujia Gomez; Nicholas R Ragan; Gillian Q Rush; Patrick Barba; Adam Santaniello; Sergio E Baranzini; Jorge R Oksenberg; Roland G Henry; Stephen L Hauser Journal: Ann Neurol Date: 2019-03-30 Impact factor: 10.422